PlentiPlex™ MSI enables a validated screening for microsatellite instability in Tumors. The test works as an aid to assist in further cancer treatments, which provides more personalised and precise treatment for the individual.
PlentiPlex™ MSI assays are intended for in vitro diagnosis of impaired mismatch repair (MMR) affecting prognosis and selection of treatment in cancer patients. PlentiPlex™ MSI assays offer three different multiplexed MSI assays for the length analysis of five microsatellite loci. The assay is not intended for diagnosing disease, but to be used as an aid that can assist treatment planning of cancer patients.
Simple MSI stratification of solid tumors for treatment guidance
Simplified four-step workflow
Well-known validated loci
Minimal hands-on time
PentaBase systems for analysis
The PlentiPlex™ MSI assays are now designed and validated to be used on BaseTyper™48(PentaBase PCR instrument) and the following instruments:
Rotor-Gene (Qiagen)
MX3000P/3005P (Agilent)
LightCycler® 96 + 480 (Roche)
CFX96TM (Bio-Rad)
ABI 7500/7900HT (Applied Biosystems)
MIC (Bio Molecular Systems)
MyGo Pro (IT-IS Life Science)
